ArticleEuropean journal of nuclear medicine and molecular imaging2023

An antibody-radionuclide conjugate targets fibroblast activation protein for cancer therapy.

Mengxin Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.